Similar articles for PMID: 26720191

Year	Number of Results
2002	1
2004	4
2005	4
2006	1
2007	8
2008	6
2009	12
2010	12
2011	14
2012	14
2013	7
2014	13
2015	11
2016	13
2017	20
2018	25
2019	12
2020	13
2021	17
2022	7
2024	0

1

Increased Risk of Obesity and Metabolic Dysregulation Following 12 Months of Second-Generation Antipsychotic Treatment in Children: A Prospective Cohort Study.

Ronsley R, Nguyen D, Davidson J, Panagiotopoulos C. Ronsley R, et al. Can J Psychiatry. 2015 Oct;60(10):441-50. doi: 10.1177/070674371506001005. Can J Psychiatry. 2015. PMID: 26720191 Free PMC article.

2

Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.

Arango C, Giráldez M, Merchán-Naranjo J, Baeza I, Castro-Fornieles J, Alda JA, Martínez-Cantarero C, Moreno C, de Andrés P, Cuerda C, de la Serna E, Correll CU, Fraguas D, Parellada M. Arango C, et al. J Am Acad Child Adolesc Psychiatry. 2014 Nov;53(11):1179-90,1190.e1-4. doi: 10.1016/j.jaac.2014.08.009. Epub 2014 Sep 2. J Am Acad Child Adolesc Psychiatry. 2014. PMID: 25440308

3

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R. Goeb JL, et al. Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. Encephale. 2010. PMID: 20620267 French.

4

Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.

Moreno C, Merchán-Naranjo J, Alvarez M, Baeza I, Alda JA, Martínez-Cantarero C, Parellada M, Sánchez B, de la Serna E, Giráldez M, Arango C. Moreno C, et al. Bipolar Disord. 2010 Mar;12(2):172-84. doi: 10.1111/j.1399-5618.2010.00797.x. Bipolar Disord. 2010. PMID: 20402710

5

Waist circumference is a sensitive screening tool for assessment of metabolic syndrome risk in children treated with second-generation antipsychotics.

Panagiotopoulos C, Ronsley R, Kuzeljevic B, Davidson J. Panagiotopoulos C, et al. Can J Psychiatry. 2012 Jan;57(1):34-44. doi: 10.1177/070674371205700107. Can J Psychiatry. 2012. PMID: 22296966

6

Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics.

Fraguas D, Merchán-Naranjo J, Laita P, Parellada M, Moreno D, Ruiz-Sancho A, Cifuentes A, Giráldez M, Arango C. Fraguas D, et al. J Clin Psychiatry. 2008 Jul;69(7):1166-75. doi: 10.4088/jcp.v69n0717. J Clin Psychiatry. 2008. PMID: 18588363 Clinical Trial.

7

Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.

Alda JA, Muñoz-Samons D, Tor J, Merchán-Naranjo J, Tapia-Casellas C, Baeza I, Calvo-Escalona R, Castro-Fornieles J, Martínez-Cantarero C, Andrés-Nestares P, Fernández-Avilés F, Arango C. Alda JA, et al. J Child Adolesc Psychopharmacol. 2016 Jun;26(5):449-57. doi: 10.1089/cap.2015.0151. Epub 2016 Jan 18. J Child Adolesc Psychopharmacol. 2016. PMID: 26779966 Clinical Trial.

8

Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.

Carbon M, Kapoor S, Sheridan E, Al-Jadiri A, Azzo S, Sarkaria T, Kane JM, Saito E, Correll CU. Carbon M, et al. J Am Acad Child Adolesc Psychiatry. 2015 Sep;54(9):718-727.e3. doi: 10.1016/j.jaac.2015.06.015. Epub 2015 Jul 7. J Am Acad Child Adolesc Psychiatry. 2015. PMID: 26299293 Free PMC article.

9

Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study.

Meyer JM, Pandina G, Bossie CA, Turkoz I, Greenspan A. Meyer JM, et al. Clin Ther. 2005 Dec;27(12):1930-41. doi: 10.1016/j.clinthera.2005.12.005. Clin Ther. 2005. PMID: 16507379 Clinical Trial.

10

Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.

Castro-Fornieles J, Parellada M, Soutullo CA, Baeza I, Gonzalez-Pinto A, Graell M, Paya B, Moreno D, de la Serna E, Arango C. Castro-Fornieles J, et al. J Child Adolesc Psychopharmacol. 2008 Aug;18(4):327-36. doi: 10.1089/cap.2007.0138. J Child Adolesc Psychopharmacol. 2008. PMID: 18759642 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

183 results

Results by year